Three U.S. senators are calling on Robert Kennedy Jr. to disclose what he and President Trump discussed with drugmakers ...

The Trump administration’s approach to cannabis reform will significantly impact the industry. As the proposed rulemaking to reschedule ...

The start-up Loyal developed a pill to extend dogs’ lifespan that has been recognized by the FDA as having “reasonable ...

This new RXE is the second to receive acceptance by the FDA for a longevity drug developed by Loyal. The first, LOY-001, ...

One Memphis man's morning took a bizarre and painful turn when he claimed his dog accidentally shot him while in bed.

This latest FDA milestone isn’t Loyal’s first; back in 2023, the company also demonstrated RXE for its drug LOY-001, designed ...

Layoffs also have occurred at FDA’s Center for Veterinary Medicine, where 11 of about 35 people reviewing animal feed ingredients have been let go, according to one source. Dana Brooks ...

October 22, 2024--FDA’s ODAC decision on checkpoint inhibitors ... AP) — Cel-Sci Corp. CVM) on Wednesday reported a loss of $7.5 million in its fiscal third quarter.

Loyal announces that the FDA’s Center for Veterinary Medicine has accepted the RXE section of its conditional approval ...

Your 8-year-old chocolate Lab is putting on weight, and you know she should probably lose a pound or two. But when she looks ...

K-State is one of four entities chosen to received Food and Drug Administration funding to work on pain management in animals, officials announced Monday.

A seemingly wonder drug for treating dogs with osteoarthritis may actually be a killer, with American authorities warning vets that “adverse events” identified include death.